HIV Funding Impacts Global health funding · LMIC Download the panel

Home  /  Latin America and the Caribbean  /  ECU

Ecuador

Ecuador appears only through international and donor bodies that compile figures across many countries, and no figures for the country are read directly from a national publisher. The assessment of national sources, country by country, is set out on the Methods page.

56,000
People living with HIV, 2025
WHO Global Health Observatory
84.0%
On antiretroviral treatment, 2025
WHO Global Health Observatory
$3k
United States HIV disbursements, 2015
ForeignAssistance.gov
$3.1m
External HIV financing, all donors, 2024
OECD Creditor Reporting System
External HIV financing
OECD CRS · ForeignAssistance.gov
$0$2m$4m$6m20022005200820112014201720202023$3.1m$48k$3.0m$3k
  • All donors
  • United States, OECD record
  • The Global Fund
  • United States, self-reported
YearAll donorsUnited States, OECD recordThe Global FundUnited States, self-reported
2002 $253k — — —
2003 $292k — — —
2004 $215k — — —
2005 $2.6m — $1.5m —
2006 $5.6m — $3.9m —
2007 $4.9m — $3.0m —
2008 $5.3m — $2.5m —
2009 $5.0m — $2.2m —
2010 $5.4m — $3.7m —
2011 $4.3m $64k $3.2m —
2012 $2.0m $114k $1.2m $179k
2013 $6.0m $62k $5.4m $57k
2014 $5.3m $48k $4.8m $51k
2015 $4.8m — $4.4m $3k
2016 $2.1m — $2.0m —
2017 $1.3m — $1.3m —
2018 $1.7m — $1.4m —
2019 $2.5m — $2.3m —
2020 $3.4m — $2.9m —
2021 $4.2m — $4.0m —
2022 $2.3m — $2.2m —
2023 $2.6m — $2.4m —
2024 $3.1m — $3.0m —

23 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment
UNAIDS AIDSinfo
020k40k60k20002003200620092012201520182021202452,00043,000
  • People living with HIV
  • People on treatment
YearPeople living with HIVPeople living with HIV (lower)People living with HIV (upper)People on treatment
2000 24,000 19,000 30,000 —
2001 26,000 21,000 31,000 —
2002 27,000 22,000 32,000 —
2003 28,000 23,000 33,000 —
2004 29,000 25,000 34,000 —
2005 30,000 26,000 35,000 —
2006 31,000 27,000 36,000 —
2007 32,000 28,000 37,000 —
2008 33,000 29,000 38,000 —
2009 34,000 31,000 40,000 —
2010 35,000 32,000 41,000 7,200
2011 37,000 33,000 42,000 8,900
2012 38,000 34,000 43,000 9,400
2013 39,000 35,000 44,000 11,000
2014 40,000 36,000 45,000 13,000
2015 41,000 37,000 46,000 15,000
2016 42,000 38,000 48,000 18,000
2017 43,000 39,000 49,000 22,000
2018 45,000 40,000 50,000 25,000
2019 46,000 42,000 52,000 31,000
2020 47,000 42,000 53,000 34,000
2021 49,000 43,000 55,000 35,000
2022 50,000 44,000 56,000 38,000
2023 51,000 45,000 58,000 41,000
2024 52,000 46,000 60,000 43,000

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade
UNAIDS AIDSinfo
0%25%50%75%2010201220142016201820202022202492.0%82.0%75.0%
  • Diagnosed
  • On treatment
  • Virally suppressed
YearDiagnosedOn treatmentVirally suppressed
2010 — 20.0% —
2011 — 24.0% —
2012 — 25.0% —
2013 — 28.0% —
2014 — 31.0% —
2015 — 38.0% —
2016 54.0% 43.0% —
2017 66.0% 50.0% —
2018 75.0% 56.0% 50.0%
2019 82.0% 67.0% 50.0%
2020 81.0% 71.0% 64.0%
2021 82.0% 71.0% 63.0%
2022 91.0% 77.0% 62.0%
2023 91.0% 80.0% 72.0%
2024 92.0% 82.0% 75.0%

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

Sources of the figures for Ecuador

2,915 rows

SourceTypeRowsIndicators YearsRead fromRetrieved
UNICEF HIV/AIDS dataset Modelled estimate 1,376 5 2010–2025 sdmx.data.unicef.org 2026-10-20
UNAIDS AIDSinfo Modelled estimate 799 28 2000–2024 aidsinfo.unaids.org 2026-10-20
WHO Global Health Observatory Modelled estimate 246 12 2000–2025 ghoapi.azureedge.net 2026-10-12
WHO Global Tuberculosis Programme Programme record 153 17 2000–2025 extranet.who.int 2026-10-16
IATI, through d-portal Expenditure account 59 3 2000–2026 d-portal.org 2026-10-12
Global Fund Data Service Programme record 55 6 2018–2025 fetch.theglobalfund.org 2026-10-12
World Bank Open Data Modelled estimate 51 2 2000–2025 api.worldbank.org 2026-10-12
OECD Creditor Reporting System Expenditure account 47 3 2002–2024 sdmx.oecd.org 2026-10-12
UNAIDS Global AIDS Monitoring expenditure database Expenditure account 38 12 2017–2022 hivfinancial.unaids.org 2026-10-12
PAHO Core Indicators Programme record 33 1 2015–2025 opendata.paho.org 2026-10-13
WHO HIV testing services dashboard Programme record 21 4 2018–2023 eic-database-290813.ew.r.appspot.com 2026-10-14
PAHO Interactive HIV Data Dashboard Programme record 14 2 2009–2025 paho.org 2026-10-14
UNAIDS Data 2025 country databook Expenditure account 11 3 2017–2022 aidsinfo.unaids.org 2026-10-15
ForeignAssistance.gov Expenditure account 8 2 2012–2015 foreignassistance.gov 2026-10-29
Global Fund allocations Expenditure account 4 1 2017–2026 fetch.theglobalfund.org 2026-10-12

Indicators held

68 of 150

IndicatorDomainUnitRows YearsSourcesMost recent value
Actual expenditure on collaborative TB/HIV activities Financing USD 5 2019–2024 WHO Global Tuberculosis Programme $73k (2024)
Budget required for collaborative TB/HIV activities Financing USD 4 2021–2025 WHO Global Tuberculosis Programme $25k (2025)
Country-reported HIV expenditure, all sources Financing USD 12 2014–2022 UNAIDS AIDSinfo, UNAIDS Global AIDS Monitoring expenditure database $12.2m (2022)
Domestic funding received by the national TB programme Financing USD 7 2018–2024 WHO Global Tuberculosis Programme $4.6m (2024)
Domestic public HIV expenditure Financing USD 12 2017–2022 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $7.7m (2022)
Expected Global Fund funding for the national TB programme Financing USD 7 2019–2025 WHO Global Tuberculosis Programme $25k (2025)
Expected USAID funding for the national TB programme Financing USD 7 2019–2025 WHO Global Tuberculosis Programme $0 (2025)
Expected domestic funding for the national TB programme Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $2.7m (2025)
Expected funding for collaborative TB/HIV activities Financing USD 4 2021–2025 WHO Global Tuberculosis Programme $25k (2025)
External HIV financing (all donors, ODA) Financing USD 23 2002–2024 OECD Creditor Reporting System $3.1m (2024)
External HIV financing from governments other than the United States (IATI) Financing USD 25 2000–2026 IATI, through d-portal $47k (2026)
External HIV financing from multilateral bodies other than the Global Fund (IATI) Financing USD 12 2015–2026 IATI, through d-portal $14k (2026)
External HIV financing from the United States (ODA) Financing USD 8 2011–2015 ForeignAssistance.gov, OECD Creditor Reporting System $3k (2015)
Funding received for collaborative TB/HIV activities Financing USD 4 2020–2024 WHO Global Tuberculosis Programme $73k (2024)
Global Fund HIV allocation for a whole three-year cycle, not an annual figure Financing USD per three-year allocation cycle 4 2017–2026 Global Fund allocations 2,974,679 (2026)
Global Fund HIV disbursements to the country Financing USD 46 2005–2026 IATI, through d-portal, OECD Creditor Reporting System, UNAIDS Global AIDS Monitoring expenditure database $2.1m (2026)
Global Fund funding received by the national TB programme Financing USD 6 2019–2024 WHO Global Tuberculosis Programme $30k (2024)
HIV spending on TB/HIV co-infection Financing USD 1 2018 UNAIDS Global AIDS Monitoring expenditure database $220k (2018)
HIV spending on critical enablers Financing USD 1 2020 UNAIDS Global AIDS Monitoring expenditure database $645k (2020)
HIV spending on governance and sustainability Financing USD 1 2018 UNAIDS Global AIDS Monitoring expenditure database $858k (2018)
HIV spending on prevention Financing USD 5 2017–2022 UNAIDS Global AIDS Monitoring expenditure database $4.8m (2022)
HIV spending on prevention of vertical transmission Financing USD 2 2017–2018 UNAIDS Global AIDS Monitoring expenditure database $560k (2018)
HIV spending on treatment, care and support Financing USD 6 2017–2022 UNAIDS Global AIDS Monitoring expenditure database $7.5m (2022)
International HIV expenditure (country-reported) Financing USD 8 2018–2022 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $4.5m (2022)
Other bilateral HIV expenditure (country-reported) Financing USD 1 2020 UNAIDS Global AIDS Monitoring expenditure database $251k (2020)
Private HIV expenditure (country-reported) Financing USD 2 2018 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $306k (2018)
US HIV disbursements managed by other US agencies Financing USD 4 2012–2015 ForeignAssistance.gov $3k (2015)
USAID funding received by the national TB programme Financing USD 4 2019–2022 WHO Global Tuberculosis Programme $0 (2022)
% of ALL PLHIV who are virally suppressed Treatment cascade percent 15 2018–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 78.0% (2025)
% of PLHIV on ART (second 95, PLHIV base) Treatment cascade percent 66 2000–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 84.0% (2025)
% of PLHIV who have been diagnosed (first 95) Treatment cascade percent 21 2016–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 93.0% (2025)
% of estimated HIV-positive incident TB cases on TB treatment and ART Treatment cascade percent 18 2003–2024 UNAIDS AIDSinfo 51.5% (2024)
% of people currently enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 2 2017–2022 UNAIDS AIDSinfo 0.8% (2022)
% of people newly enrolled in HIV treatment diagnosed with TB disease Treatment cascade percent 8 2016–2024 UNAIDS AIDSinfo 16.6% (2024)
% of people newly enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 5 2014–2021 UNAIDS AIDSinfo 2.6% (2021)
% of people on ART who are virally suppressed (third 95) Treatment cascade percent 8 2018–2025 WHO Global Health Observatory 93.0% (2025)
% of returned HIV test results that were positive Treatment cascade percent 17 2018–2023 UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 0.6% (2023)
HIV tests performed at a health facility Treatment cascade count 1 2022 WHO HIV testing services dashboard 907,500 (2022)
HIV tests performed through community outreach Treatment cascade count 2 2018–2022 WHO HIV testing services dashboard 31,031 (2022)
HIV tests performed with the result returned to the person Treatment cascade count 22 2018–2024 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 86,713 (2024)
HIV-exposed infants tested within two months of birth Treatment cascade percent 11 2010–2024 UNAIDS AIDSinfo 62.0% (2024)
HIV-positive TB patients started or continued on ART Treatment cascade count 12 2015–2024 WHO Global Tuberculosis Programme 1,031 (2024)
Key-population people tested for HIV (count over the period) Treatment cascade count 15 2020–2025 Global Fund Data Service By population group, sex or age only, to 2025
New HIV diagnoses with a CD4 count below 200 Treatment cascade percent 4 2017–2020 UNAIDS AIDSinfo 18.0% (2020)
Notified HIV cases, national case surveillance Treatment cascade count 39 2009–2025 PAHO Core Indicators, PAHO Interactive HIV Data Dashboard 4,678 (2025)
Number of people on ART (PEPFAR MER TX_CURR) Treatment cascade count 74 2000–2025 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO Global Tuberculosis Programme 47,080 (2025)
PMTCT ART coverage among pregnant women with HIV Treatment cascade percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 75.0% (2025)
People living with HIV on ART who started TB preventive therapy Treatment cascade count 3 2023–2025 Global Fund Data Service 1,672 (2025)
People newly enrolled on ART during the year Treatment cascade count 8 2016–2024 WHO Global Tuberculosis Programme 4,778 (2024)
People on ART on a dolutegravir-based regimen Treatment cascade percent 8 2022–2025 PAHO Interactive HIV Data Dashboard By population group, sex or age only, to 2025
Pregnant women tested for HIV in antenatal care Treatment cascade percent 15 2010–2024 UNAIDS AIDSinfo 87.0% (2024)
Pregnant women with HIV who received ARVs for PMTCT Treatment cascade count 31 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 538 (2025)
TB patients recorded as HIV-positive Treatment cascade count 13 2015–2024 WHO Global Tuberculosis Programme 1,031 (2024)
TB patients with an HIV test result recorded Treatment cascade count 13 2015–2024 WHO Global Tuberculosis Programme 6,181 (2024)
AIDS-related deaths Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 500 (2025)
Deaths from TB among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 300 (2024)
HIV prevalence among a key population Epidemic estimates percent 4 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
HIV prevalence, ages 15-49 Epidemic estimates percent 50 2000–2024 UNAIDS AIDSinfo, World Bank Open Data 0.4% (2024)
Incident TB cases among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 2,000 (2024)
New HIV infections Epidemic estimates count 585 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 2,000 (2025)
People living with HIV Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 56,000 (2025)
Key-population people reached by outreach (count over the period) Prevention and outreach count 15 2020–2025 Global Fund Data Service By population group, sex or age only, to 2025
Male condoms distributed in a year Prevention and outreach count 3 2019–2024 UNAIDS AIDSinfo 5,657,796 (2024)
People receiving PrEP Prevention and outreach count 14 2020–2025 Global Fund Data Service, UNAIDS AIDSinfo 3,900 (2024)
Estimated pregnant women with HIV needing ARVs for PMTCT Population denominators count 31 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 720 (2025)
Estimated size of a key population Population denominators count 3 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Total population Population denominators count 26 2000–2025 World Bank Open Data 18,289,896 (2025)
Share of HIV-exposed infants who acquire HIV — percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 13.8% (2025)

Every row shown on the Ecuador page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.